{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:36:48Z","timestamp":1793313408273,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jchf.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T16:02:16Z","timestamp":1701446536000},"page":"525-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Meta-Analysis and Metaregression of the\u00a0Treatment Effect of Intravenous Iron\u00a0in Iron-Deficient Heart\u00a0Failure"],"prefix":"10.1016","volume":"12","author":[{"given":"Pieter","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Silvio Nunes","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jchf.2023.11.006_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jchf.2023.11.006_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2023.11.006_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.amjcard.2016.09.017","article-title":"Impact of iron deficiency on response to and remodeling after cardiac resynchronization therapy","volume":"119","author":"Martens","year":"2017","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.jchf.2023.11.006_bib4","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"48","key":"10.1016\/j.jchf.2023.11.006_bib5","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1093\/eurheartj\/ehab411","article-title":"The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial","volume":"42","author":"Martens","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jchf.2023.11.006_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"10266","key":"10.1016\/j.jchf.2023.11.006_bib7","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.jchf.2023.11.006_bib8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"10369","key":"10.1016\/j.jchf.2023.11.006_bib9","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jchf.2023.11.006_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008100","article-title":"Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design","volume":"14","author":"Mentz","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.jchf.2023.11.006_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jchf.2023.11.006_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"15","key":"10.1016\/j.jchf.2023.11.006_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/eurjpc\/zwaa119","article-title":"Iron deficiency in heart failure-time to redefine","volume":"28","author":"Martens","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"22","key":"10.1016\/j.jchf.2023.11.006_bib14","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/eurheartj\/ehad149","article-title":"Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications","volume":"44","author":"Martens","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jchf.2023.11.006_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jchf.2023.11.006_bib16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jchf.2023.11.006_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jchf.2023.11.006_bib18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.jchf.2023.11.006_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jchf.2023.11.006_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ejhf.161","article-title":"Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis","volume":"16","author":"Yeo","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.jchf.2023.11.006_bib21","doi-asserted-by":"crossref","first-page":"FSO467","DOI":"10.2144\/fsoa-2019-0156","article-title":"Effect of ferric-carboxy maltose on oxygen kinetics and functional status in heart failure patients with iron deficiency","volume":"6","author":"Dhoot","year":"2020","journal-title":"Future Sci OA"},{"issue":"2","key":"10.1016\/j.jchf.2023.11.006_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FJC.0000000000001287","article-title":"IV sodium ferric gluconate complex in patients with\u00a0iron deficiency hospitalized due to acute heart\u00a0failure-investigator initiated, randomized controlled trial","volume":"80","author":"Marcusohn","year":"2022","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"48","key":"10.1016\/j.jchf.2023.11.006_bib23","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jchf.2023.11.006_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ejhf.837","article-title":"Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up","volume":"19","author":"Van Aelst","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"44","key":"10.1016\/j.jchf.2023.11.006_bib25","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","article-title":"Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use","volume":"40","author":"van der Wal","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jchf.2023.11.006_bib26","first-page":"362","article-title":"Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure","volume":"38","author":"Haddad","year":"2017","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jchf.2023.11.006_bib27","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human\u00a0cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.jchf.2023.11.006_bib28","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ejhf.1174","article-title":"Cardiac iron deficiency-how to refuel the engine out of fuel","volume":"20","author":"Martens","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.jchf.2023.11.006_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","article-title":"Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure","volume":"58","author":"Maeder","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jchf.2023.11.006_bib30","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.2489","article-title":"The effect of intravenous ferric carboxymaltose on right ventricular function - insights from the IRON-CRT trial","volume":"24","author":"Martens","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jchf.2023.11.006_bib31","article-title":"Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the Myocardial-IRON trial","volume":"9","author":"Nunez","year":"2020","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177923007576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177923007576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:04:41Z","timestamp":1761973481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177923007576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2213177923007576"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2023.11.006","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis and Metaregression of the\u00a0Treatment Effect of Intravenous Iron\u00a0in Iron-Deficient Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}